DRAGONFLY THERAPEUTICS Trademark

Trademark Overview

On Tuesday, July 5, 2016, a trademark application was filed for DRAGONFLY THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DRAGONFLY THERAPEUTICS trademark a serial number of 87092750. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, February 7, 2024. This trademark is owned by Equipoise Therapeutics Corporation. The DRAGONFLY THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of immunotherapy drugs for cancer treatment
dragonfly therapeutics

General Information

Serial Number87092750
Word MarkDRAGONFLY THERAPEUTICS
Filing DateTuesday, July 5, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, February 7, 2024
Registration Number5272538
Registration DateTuesday, August 22, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development of immunotherapy drugs for cancer treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2016
Primary Code042
First Use Anywhere DateTuesday, November 1, 2016
First Use In Commerce DateTuesday, November 1, 2016

Trademark Owner History

Party NameDragonfly Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameDragonfly Therapeutics, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressOne Kendall Square, MA 02139
Party NameEquipoise Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOne Kendall Square, MA 02139
Party NameEquipoise Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOne Kendall Square, MA 02139

Trademark Events

Event DateEvent Description
Wednesday, February 7, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, February 7, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, February 7, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 17, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, August 22, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 22, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, July 18, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 17, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 27, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, May 19, 2017USE AMENDMENT FILED
Monday, June 19, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 19, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, May 17, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 14, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 7, 2016ASSIGNED TO LIE
Monday, October 24, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, October 23, 2016EXAMINER'S AMENDMENT ENTERED
Sunday, October 23, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, October 23, 2016EXAMINERS AMENDMENT E-MAILED
Sunday, October 23, 2016EXAMINERS AMENDMENT -WRITTEN
Sunday, October 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 23, 2016NON-FINAL ACTION E-MAILED
Sunday, October 23, 2016NON-FINAL ACTION WRITTEN
Friday, October 14, 2016ASSIGNED TO EXAMINER
Thursday, July 14, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, July 14, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2016NEW APPLICATION ENTERED

Related Keywords

therapeutics dragonfly cancer treatment drugs immunotherapy development research